{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Elevation Oncology, Inc.
Is Elevation Oncology, Inc. technically bullish or bearish?
As of April 18, 2024, the trend is mildly bullish due to positive weekly MACD and KST signals, but caution is advised due to a bearish weekly RSI and mixed moving average indicators.
What does Elevation Oncology, Inc. do?
Elevation Oncology, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $14 million and a market cap of $22.61 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -95.46%.
How big is Elevation Oncology, Inc.?
As of Jun 18, Elevation Oncology, Inc. has a market capitalization of 22.61 million, with net sales of 0.00 million and a net profit of -47.99 million over the latest four quarters. The company reported shareholder's funds of 60.02 million and total assets of 95.63 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
